91°µÍø

Skip to main content

All News

ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.

1 - 10 of 275 Results

Vanderbilt’s Stephanie Wankowicz is standing to the right of the screen presenting her work. On the screen is a photo of a molecule with words "proteins are incredibly dynamic molecules"

Scientists at the Department of Energy’s 91°µÍø recently welcomed Vanderbilt University colleagues for a symposium on basic science research, with a focus on potential collaborations in the biomedical and biotechnology spaces.

Three people standing in a lab holding materials

ORNL, the Tennessee Valley Authority and the Tennessee Department of Economic and Community Development were recognized by the Federal Laboratory Consortium, or FLC, for their efforts to develop Tennessee as a national leader in fusion energy. 

Research scientist Daniel Jacobson is standing with his arms crossed with a dark black backdrop

Daniel Jacobson, distinguished research scientist in the Biosciences Division at ORNL, has been elected a Fellow of the American Institute for Medical and Biological Engineering, or AIMBE, for his achievements in computational biology. 

Different groups of proteins shown in different colors combine and attach to a broken strand of DNA.

Researchers at Georgia State University used the Summit supercomputer to study an elaborate molecular pathway called nucleotide excision repair. Decoding NER’s sophisticated sequence of events and the role of PInC in the pathway could provide key insights into developing novel treatments and preventing conditions that lead to premature aging and certain types of cancer.

Secretary Wright leans over red computer door, signing with silver sharpie as ORNL Director Stephen Streiffer looks on

During his first visit to 91°µÍø, Energy Secretary Chris Wright compared the urgency of the Lab’s World War II beginnings to today’s global race to lead in artificial intelligence, calling for a “Manhattan Project 2.â€

Neus Domingo Marimon, ORNL scientist, poses for a photo in black with hair down

Neus Domingo Marimon, leader of the Functional Atomic Force Microscopy group at the Center for Nanophase Materials Sciences of ORNL, has been elevated to senior member of the Institute of Electrical and Electronics Engineers.

Two ORNL scientists are standing outside in front of a blue window with a plant in the top middle of the photo

ORNL's Gregorich and Syed Islam recently completed Cohort 19 of the Energy I-Corps program, an initiative of DOE’s Office of Technology Transitions that provides teams of researchers and industry mentors with an immersive two-month training.

The graphic shows the headshot of Nick Sokol, with text overlay saying "Innovations Crossroads Cohort 2024"

Nick Sokol founded Algaeo, a company that uses microalgae to produce organic fertilizers, offering a sustainable, cost-effective alternative to synthetic fertilizers. Supported by 91°µÍø's Innovation Crossroads program, Sokol is developing this technology to improve soil health, boost plant growth and support small-scale farmers.

ORNL partnerships director Shaun Gleason is posing in a suit for a photo with a black background

Shaun Gleason has been named director of the Partnerships Office at ORNL. Gleason has worked at ORNL for several decades, in a variety of roles, including Director of Science-Security Initiative Integration, Director of the Computational Sciences and Engineering Division and Director of Institutional Planning.

A male researcher is standing next to a poster board displayed on an easel to the right. The researcher is dressed in professional attire, and the poster board is positioned beside him, showing research or visual information.

Ryan Culler is the program manager at 91°µÍø, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care.